Literature DB >> 6304334

Presence of leader sequences in the mRNA of mouse hepatitis virus.

M M Lai, C D Patton, R S Baric, S A Stohlman.   

Abstract

To determine the structure and the mechanism of synthesis of mouse hepatitis virus mRNA, the map positions of the large RNase T1-resistant oligonucleotides of the seven mouse hepatitis virus strain A59 intracellular mRNA species were studied. We found that all but one of the oligonucleotides were mapped at the positions within each mRNA consistent with the nested-set, stairlike structure of mouse hepatitis virus mRNA (Lai et al., J. Virol. 39:823-834). However, one oligonucleotide, 10, was mapped near the 5' ends of every mRNA and virion genomic RNA. In other words, oligonucleotide 10 and, therefore, the sequences around the 5' ends of the mRNAs are not colinear with the genomic sequences. Because this oligonucleotide is present only once in the genomic RNA, this result indicates that oligonucleotide 10 is not transcribed from multiple sites on the genomic template, but rather represents a leader RNA sequence which is joined to the body sequences of the different mRNAs during mRNA transcription. This provides the most direct evidence thus far for the presence of leader sequences in the mRNAs of mouse hepatitis virus, which is a cytoplasmic virus. Several possible mechanisms of RNA synthesis are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304334      PMCID: PMC256579     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  12 in total

1.  Genomic RNA of the murine coronavirus JHM.

Authors:  H Wege; A Müller; V ter Meulen
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

2.  RNA of mouse hepatitis virus.

Authors:  M M Lai; S A Stohlman
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

3.  Synthesis of subgenomic mRNA's of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping.

Authors:  L Jacobs; W J Spaan; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

4.  Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides.

Authors:  M M Lai; C D Patton; S A Stohlman
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  Sequence relationships between the genome and the intracellular RNA species 1, 3, 6, and 7 of mouse hepatitis virus strain A59.

Authors:  W J Spaan; P J Rottier; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

6.  The replication of murine coronaviruses in enucleated cells.

Authors:  K C Wilhelmsen; J L Leibowitz; C W Bond; J A Robb
Journal:  Virology       Date:  1981-04-15       Impact factor: 3.616

7.  Comparative analysis of RNA genomes of mouse hepatitis viruses.

Authors:  M M Lai; S A Stohlman
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

8.  Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3.

Authors:  M M Lai; P R Brayton; R C Armen; C D Patton; C Pugh; S A Stohlman
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

9.  Host cell nuclear function and murine hepatitis virus replication.

Authors:  P R Brayton; R G Ganges; S A Stohlman
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

10.  Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59).

Authors:  W J Spaan; P J Rottier; M C Horzinek; B A van der Zeijst
Journal:  Virology       Date:  1981-01-30       Impact factor: 3.616

View more
  93 in total

1.  Subgenomic messenger RNA amplification in coronaviruses.

Authors:  Hung-Yi Wu; David A Brian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-18       Impact factor: 11.205

Review 2.  The novel human coronaviruses NL63 and HKU1.

Authors:  Krzysztof Pyrc; Ben Berkhout; Lia van der Hoek
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Replication of murine coronavirus defective interfering RNA from negative-strand transcripts.

Authors:  M Joo; S Banerjee; S Makino
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein.

Authors:  S C Baker; C K Shieh; L H Soe; M F Chang; D M Vannier; M M Lai
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  High-frequency leader sequence switching during coronavirus defective interfering RNA replication.

Authors:  S Makino; M M Lai
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase.

Authors:  L H Soe; C K Shieh; S C Baker; M F Chang; M M Lai
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus.

Authors:  S Makino; N Fujioka; K Fujiwara
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

8.  Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis.

Authors:  S G Sawicki; D L Sawicki
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

9.  Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis.

Authors:  X Zhang; C L Liao; M M Lai
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus.

Authors:  M M Lai; R S Baric; P R Brayton; S A Stohlman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.